Concepedia

Tahirih L. Lamothe

TL

Statistics

Publications

2

Citations

57

H-Index

2

Active since

2019

Affiliations

Fate Therapeutics (United States)(Current)

Tahirih L. Lamothe is an author at Fate Therapeutics (United States) specializing in antibody-drug conjugate antibodies, curative therapy, and donor-recipient chimerism.

Publications per year

2019–2022

2

Publications

2

A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice

Asim Saha, Sharon L. Hyzy, Tahirih L. Lamothe et al. · Blood · 2022 · 47 citations · Full text

, , +17

A CD117-Amanitin Antibody Drug Conjugate (ADC) Effectively Depletes Human and Non-Human Primate Hematopoietic Stem and Progenitor Cells (HSPCs): targeted Non-Genotoxic Conditioning for Bone Marrow Transplant

Bradley R. Pearse, Sean M. McDonough, Jennifer Proctor et al. · Biology of Blood and Marrow Transplantation · 2019 · 10 citations · Full text

, , +15

1–2 of 2